Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
ALBPS | PA
Overview
Corporate Details
- ISIN(s):
- FR0012816825 (+4 more)
- LEI:
- 9695008GIE061NBGU106
- Country:
- France
- Address:
- 14 AVENUE DE L'OPERA, 75001 PARIS
- Website:
- https://www.biophytis.com/en/
Description
Biophytis S.A. is a clinical-stage biotechnology company focused on developing therapeutics to slow degenerative processes associated with aging and improve longevity. The company's primary strategy is centered on treating diseases that impair mobility. Its lead drug candidate, BIO101, is being advanced in late-stage clinical development for multiple age-related conditions. A key program is the SARA Phase 3 trial, the first-ever pivotal study for the treatment of sarcopenia (age-related muscle loss). Additionally, BIO101 is being evaluated in the OBA Phase 2 clinical trial for addressing muscle wasting in patients with obesity. The company aims to preserve muscle function and enhance functional outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-28 22:00 |
Biophytis announces the settlement and delivery of its €2.6 million private pla…
|
English | 534.3 KB | ||
| 2025-03-28 22:00 |
Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions…
|
French | 340.2 KB | ||
| 2025-03-26 07:35 |
Biophytis announces the successful completion of a €2,6 million private placeme…
|
English | 381.7 KB | ||
| 2025-03-26 07:35 |
Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros
|
French | 381.0 KB | ||
| 2025-03-24 07:30 |
Biophytis announces new non-clinical data further supporting its mission to pio…
|
English | 242.6 KB | ||
| 2025-03-24 07:30 |
Biophytis annonce de nouvelles données non cliniques renforçant sa mission de p…
|
French | 233.1 KB | ||
| 2025-03-17 07:00 |
Biophytis révolutionne la sarcopénie
|
French | 335.2 KB | ||
| 2025-03-17 07:00 |
Biophytis revolutionizes sarcopenia
|
English | 330.7 KB | ||
| 2025-03-06 07:00 |
Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan
|
English | 159.5 KB | ||
| 2025-03-06 07:00 |
Biophytis annonce sa participation à la conférence BIO-Europe Spring à Milan
|
French | 160.2 KB | ||
| 2025-02-25 07:00 |
Biophytis announces its participation in the 15th International Conference on F…
|
English | 172.6 KB | ||
| 2025-02-25 07:00 |
Biophytis annonce sa participation au 15ème Congrès International sur la Fragil…
|
French | 190.2 KB | ||
| 2025-02-11 07:00 |
Biophytis dévoile ses perspectives stratégiques de l’année 2025
|
French | 185.2 KB | ||
| 2025-02-11 07:00 |
Biophytis unveils its outlook strategies for 2025
|
English | 172.1 KB | ||
| 2025-01-27 07:00 |
Biophytis annonce sa participation à la conférence investisseurs BIOMED FORUM
|
French | 169.0 KB |
Automate Your Workflow. Get a real-time feed of all Biophytis S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biophytis S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biophytis S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-22 | N/A | Other | Buy | 8,443,190 | 79,365.99 EUR |
| 2020-12-16 | N/A | Other | Sell | 500,000 | 499,000.00 EUR |
| 2020-12-16 | N/A | Other | Other | 313,417 | N/A |
| 2020-04-30 | N/A | Other | Other | 2,955,701 | 177,342.06 EUR |
Peer Companies
